Biotricity Expands Distribution of New Bioheart Device on Amazon.com

3 years ago

New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your SmartphoneNow Easy to Buy and Use: No Prescription…

American Family Care Smashes Franchise Development Records

3 years ago

Nation's Largest Provider of Urgent Care Capitalizes on Interest in Healthcare Industry InvestmentsBIRMINGHAM, AL / ACCESSWIRE / December 28, 2021…

PacBio’s New HiFiViral Surveillance Kit Performance is Not Impacted by Omicron Mutations, Delivering Complete SARS-CoV-2 Genomes for All Circulating Variants

3 years ago

HiFiViral Solution helps to accelerate understanding of the Omicron variant, providing information that is important to public health responseMENLO PARK,…

Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier Hospitals

3 years ago

Both hospitals belong to large hospital systems representing future growth opportunitiesROSELAND, N.J., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc.…

BioVie to Participate at the LifeSci Partners 11th Annual Corporate Access Event

3 years ago

RENO, Nev., Dec. 28, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing…

Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation

3 years ago

STOUGHTON, Mass., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being…

Baudax Bio Announces $4.2 Million Registered Direct Offering

3 years ago

MALVERN, Pa., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on commercializing…

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

3 years ago

DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing,…

Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS

3 years ago

HAMILTON, Bermuda, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio…

Correction: Regarding results of a share buy-back offer

3 years ago

Joint stock company “Olainfarm”, hereinafter referred to as - “the Company”, hereby informs that on the 27th of December, 2021 joint…